Duodenal-jejunal bypass liners: Outcomes in glycaemic control and weight loss

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 5, 2013, Pages 420-428

  Neff, Karl J ^a   Miras, Alex D ^b   Le Roux, Carel ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

diabetes; duodenaljejunal bypass liner; EndoBarrier; gastric bypass

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; LIPID;

BLOOD PRESSURE; BODY WEIGHT; DIGESTIVE DEVICE; DUODENAL JEJUNAL BYPASS LINER; ENDOSCOPY; ENERGY EXPENDITURE; EXPLANT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; IMPLANTATION; INTESTINE BYPASS; LOCOMOTION; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; REVIEW; SYSTEMATIC REVIEW; THERMOGENESIS; TREATMENT DURATION; WEIGHT REDUCTION;

BLOOD GLUCOSE; DUODENUM; GASTRIC BYPASS; HUMANS; JEJUNOILEAL BYPASS; JEJUNUM; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84883657433     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/01.med.0000433057.84323.2e     Document Type: Review

References (28)

1. Azagury DE, Lautz DB. Obesity overview: epidemiology, health and financial impace, and guidelines for qualification for surgical therapy. Gastrointest Endosc Clin N Am 2011; 21:189-201.
2. Centers for Disease Control and Prevention (CDC). Overweight and obesity: causes and consequences. http://www.cdc.gov/obesity/adult/causes/index.html. [Accessed on 3 October 2012].
3. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide. Obes Surg 2013; 23:427-436.
4. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007; 14:275-278.
5. Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 2012; 18:950-955.
6. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring) 2012; 20:1266-1272.
7. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010; 251:236-243.
8. Cohen RV, Neto MG, Correa JL, et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab 2013; 98:E279-E282.
9. Escalona A, Pimentel F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 2012; 255:1080-1085.
10. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71:976-982.
11. de Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2012; 14:183-189.
12. Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig 2012; 104:72-87.
13. Levine A, Ramos A, Escalona A, et al. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes. Surg Obes Relat Dis 2009; 5:371-374.
14. Patel SR, Hakim D, Mason J, Hakim N. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis 2013; 9:482-484.
15. Cohen RV, Papamargaritis D, Salles JE, et al. The role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes. Diabet Med 2013. [Epub ahead of print]
16. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for preoperative weight loss in bariatric surgery. Surg Endosc 2009; 23:650-656.
17. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 2009; 11:725-732.
18. Escalona A, Yanez R, Pimentel F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis 2010; 6:126-131.
19. de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013; 23:1354-1360.
20. Munoz R, Dominguez A, Munoz C, et al. Baseline glycated haemoglobin levels predict Endobarrier-induced weight loss in morbidly obese patients with and without type 2 diabetes; Society of Gastrointestinal and Endoscopic Surgeons Annual Conference; 2013 Apr 17-20; Baltimore, USA; 2013.
21. Escalona A, Pimentel F, Munoz C, et al. Two year follow-up and reimplantation of the endoscopic duodenal-jejunal bypass liner; 5th International Federation of Surgery for Obesity and Metabolic Disorders European Chapter Meeting; 2012 Apr 26-28. Barcelona, Spain; 2012.
22. Escalona A, Pimentel F, Munoz C, et al. Durable weight loss and metabolic improvement at two years with the Endobarrier DJBL; TheObesity Society 30th Annual Scientific Meeting; 2012 Sept 20-24. San Antonio, Texas, USA; 2012.
23. Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 2008; 16:2585-2592.
24. Munoz R, Carmody JS, Stylopoulos N, et al. Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in dietinduced obese rats. Am J Physiol Regul Integr Comp Physiol 2012; 303:R985-R993.
25. de Moura EG, Orso IR,Martins Bda C, et al. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg 2011; 21:941-947.
26. Rodriguez-Grunert L,Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4:55-59.
27. de Jonge CV, Verdam FJ, Rensen SS, et al. Endobarrier gastrointestinal liner repaidly improves diabetes parameters paralleled by increased GLP-1 and PYY levels in obese type 2 diabetes patients. 2011. Chirurgendagen (Association of Surgeons in the Netherlands) 19-20 May 2011; Br J Surg. 98: s6. doi: 10.1002/bjs.7643.
28. Tong PC, Kong AP, So WY, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30:1206-1211. (Pubitemid 46684649)